Current and Emerging Therapies for Schizophrenia: How MOA Affects Clinical Outcomes
| Overview / Abstract: |
Clinical trial data that addresses the safety and efficacy of antipsychotics is continuously emerging, with a focus on optimizing the management of schizophrenia. These data include the identification of strategies with novel mechanisms of action (MOAs) to effectively resolve symptoms and promote recovery while minimizing metabolic effects. The second episode of this schizophrenia CMEOcast podcast series explores the MOAs of current and emerging therapies for schizophrenia. Expert faculty feature pertinent information on differentiating these MOAs as well as their influence on clinical outcomes, and learners have the option of an audio-only version of the episode or to view it with the additional resource of a faculty-guided tour of an animated 3-D model. Access, explore, and share this 3-D model with your patients and their caregivers to enhance knowledge related to treatment decision-making. |
|
Expiration |
Nov 21, 2020 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Psychology CE |
|
Format |
Podcast |
|
Credits / Hours |
0.5 AMA PRA Category 1 Credit(s)TM/contact hours/CEUs |
|
Accreditation |
ACCME, ACPE, ABIM, MACRA, AAPA, AANP |
|
Presenters / Authors / Faculty |
Christoph U. Correll, MD |
|
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Alkermes, Inc. |
|
Keywords / Search Terms |
CME Outfitters, LLC schizophrenia, mental health, mental illness, psychiatry, neuroscience, psych Free CE CME |
|